Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | YMAB | Employee Stock Option (right to buy) | Award | $0 | +133K | $0.00 | 133K | Jan 18, 2024 | Common Stock | 133K | $9.83 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | Represents 22,100 restricted stock units ("RSUs") granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 18, 2025, January 18, 2026 and January 18, 2027 subject to the continuing employment of the Reporting Person on each vesting date. |
F2 | Reporting Person is sole member of GAD Enterprises, LLC and the sole member and manager of GAD Management, LLC, the manager of GAD Enterprises, LLC, and as such Reporting Person has sole voting and dispositive power with respect to such shares. |
F3 | Represents shares owned by Reporting Person's children who are deemed to share Reporting Person's household. |
F4 | Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. |
F5 | The stock options shall vest and become exercisable as to 25% of the shares subject to the option on January 18, 2025, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
Exhibit 24 - Power Of Attorney